MedicarePartD.guide

A non-government resource built from CMS public data

Rinvoq on Prescription Blue Premium (S5584-002)

upadacitinib

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 31 per 31 days.

$2,262.43
Patient pays / month
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

RINVOQ 30 mg Tablet, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $6,855.86 for a month. Other covered strengths are listed below.

Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
RINVOQ 45 mg Tablet, Extended Release5$4,527.41PA · 31 per 31 days
RINVOQ 15 mg Tablet, Extended Release5$6,834.22PA · 93 per 31 days
RINVOQ 30 mg Tablet, Extended Release5$2,262.43PA · 31 per 31 days
RINVOQ 1 mg/mL Solution5$2,296.93PA · 360 per 30 days

Other JAK inhibitors on this plan

Verify with the plan before prescribing or filling. Member services: (800)565-1770. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5584-002